IP Verse

Oral Dosage Form Comprising Rifaximin In Form Beta

Patent No. EP3416627 (titled "Oral Dosage Form Comprising Rifaximin In Form Beta") was filed by Sandoz on Apr 25, 2018. The application was issued on Apr 22, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALFASIGMAAug 27, 2020KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3416627

SANDOZ
Application Number
EP18718476A
Filing Date
Apr 25, 2018
Status
Revoked
May 4, 2024
Publication Date
Apr 22, 2020
External Links
Slate, Register , Google Patents